Cargando…

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?

Detalles Bibliográficos
Autores principales: Dauby, Nicolas, Bottieau, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567655/
https://www.ncbi.nlm.nih.gov/pubmed/33075529
http://dx.doi.org/10.1016/j.ijid.2020.10.032
_version_ 1783596371603881984
author Dauby, Nicolas
Bottieau, Emmanuel
author_facet Dauby, Nicolas
Bottieau, Emmanuel
author_sort Dauby, Nicolas
collection PubMed
description
format Online
Article
Text
id pubmed-7567655
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-75676552020-10-19 The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? Dauby, Nicolas Bottieau, Emmanuel Int J Infect Dis Letter to the Editor The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-02 2020-10-17 /pmc/articles/PMC7567655/ /pubmed/33075529 http://dx.doi.org/10.1016/j.ijid.2020.10.032 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Dauby, Nicolas
Bottieau, Emmanuel
The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title_full The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title_fullStr The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title_full_unstemmed The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title_short The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
title_sort unfinished story of hydroxychloroquine in covid-19: the right anti-inflammatory dose at the right moment?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567655/
https://www.ncbi.nlm.nih.gov/pubmed/33075529
http://dx.doi.org/10.1016/j.ijid.2020.10.032
work_keys_str_mv AT daubynicolas theunfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment
AT bottieauemmanuel theunfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment
AT daubynicolas unfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment
AT bottieauemmanuel unfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment